BioSpace News Archive

Policy

Mylan and Biocon Receive Approvals from the European Commission and TGA Australia for Semglee™, Biosimilar Insulin Glargine

Mylan N.V. and Biocon Ltd. announced that their co-developed biosimilar insulin glargine Semglee™ has received marketing authorization approval from the European Commission (EC).

March 27, 2018
·
5 min read
Tetra Bio-Pharma Inc. Announces the Closing of $4,292,000 Non-Brokered Private Placement

Tetra Bio-Pharma Inc. is pleased to announce it has closed its non-brokered private placement of 4,292,000 units at a price of $1.00 per unit for aggregate gross proceeds of $4,292,000.

March 27, 2018
·
1 min read
BioMidwest

Siemens Expanding Investments in U.S. Digital Capabilities Including $175 Million R&D Ramp Up

Eight new U.S.-based MindSphere Application Centers for digital applications – transforming data into real value for customers.

March 27, 2018
·
6 min read
Policy

TriAltus Bioscience Announces Licensing Agreement with UAB and Begins to Commercialize Novel Protein Purification Technology

New method saves time, increases yield and purity, and reduces protein preparation costs

March 27, 2018
·
2 min read
Business

Bovie Medical Corporation Announces Appointment of Scott R. Sanders as Director of Clinical Education and Market Development

Bovie Medical Corporation (NYSEMKT:BVX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product, today announced the appointment of Scott R. Sanders as Director of Clinical Education and Market Development.

March 27, 2018
·
4 min read
Policy

NanoSphere Health Sciences Awarded Breakthrough Patent for Disruptive Nanoparticle Delivery Platform

Landmark patent marks most significant advancement in over 25 years for non-invasive medical delivery systems

March 27, 2018
·
4 min read
Job Trends

Beacon Point Recovery Center Looking To Hire Over 150 People Hosting Job Fair At Sugar House Casino

Beacon Point seeks 150 individuals for positions in Port Richmond location

March 27, 2018
·
1 min read
Policy

Constant Pharmaceuticals, LLC Announces European Patent Issuance for TXA127 in Treatment of Stroke

Constant Pharmaceuticals, LLC announced that the European Patent Office (EPO) has notified the company that it will grant a patent covering the use of TXA127 in the treatment of stroke.

March 27, 2018
·
2 min read
Deals

Homology Medicines Announces Pricing of Initial Public Offering

Homology Medicines, Inc. announced the pricing of its initial public offering of 9,000,000 shares of common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions.

March 27, 2018
·
1 min read
Business

Be The Match BioTherapies Expands Leadership Team with Promotions and New Hires

“As we continue to pursue our mission to support companies developing new cellular therapies with strong potential to improve patient outcomes in a range of disease areas, we are delighted to announce these key additions and promotions,” said Amy Ronneberg, President of Be The Match BioTherapies.

March 27, 2018
·
5 min read